[1] |
Tsuta K,Ishii G,Kim E,et al.Primary lung adenocarcinoma with massive lymphocyte infiltration.Am J Clin Pathol,2005,123:547-552.
|
[2] |
Canna K,Mc Ardle P A,Mc Millan D C,et al.The relationship between tumour T-lymphocyte infiltration,the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.Br J Cancer,2005,92:651-654.
|
[3] |
Tavassoli F A,Devilee P.WHO classification of tumors:pathology,genetics,tumors of the breast and female genital organs.Lyon:IARC Press,2003:35-36.
|
[4] |
Tresserra F,Grases P J,Fabregas R,et al.Invasive micropapillary carcinoma:distinct features of a poorly recognized variant of breast carcinoma.Eur J Gynaecol Oncol,1999,20:205-208.
|
[5] |
Middleton L P,Tressera F,Sobel M E,et al.Infiltrating micropapillary carcinoma of the breast.Mod Pathol,1999,12:499-504.
|
[6] |
Luna More S,Casquero S,Perez-Mellado A,et al.Importance of eatrogen receptor for the behavior of invasive micropapillary carcinoma of the breast:review of 68 cases with follow-up of 54 months.Pathol Res Pract,2000,196:35-39.
|
[7] |
Luna More S,Gonzalez B,Acedo C,et al.Invasive micropapillary carcinoma of the breast:a new special type of invasive mammary carcinoma.Pathol Res Pract,1994,190:668-674.
|
[8] |
Tsumagari K,Sakamoto G,Akiyama F,et al.The pathological diagnosis and clinical significance of invasive micropapillary carcinoma of the breast.Jpn J Breast Cancer,2001,16:441-447.
|
[9] |
Nassar H,Wallis T,Andea A,et al.Clinicopathologic analysis of invasive micropapillary differenciation in breast carcinoma.Mod Pathol,2001,14:836-841.
|
[10] |
陈凌,范宇,郎荣刚,等.伴有浸润性微乳头状癌结构乳腺癌的诊断和预后研究.中华病理学杂志,2007,36:228-231.
|
[11] |
Guo X,Chen L,Lang R,et al.Invasive micropapillary carcinoma of the breast:association of pathologic features with lymph node metastasis.Am J Clin Pathol,2006,126:740-746.
|
[12] |
Rapin V,Contesso G,Mouriesse H,et al.Medullary breast carcinoma:a reevaluation of 95 cases of breast cancer with inflammatory stroma.Cancer,1998,61:2503-2510.
|
[13] |
Wargotz E S,Silverbreg S G.Medullary carcinoma of the breast:a clinicopathologic study with appraisal of current diagnostic criteria.Hum Pathol,1998,19:1340-1346.
|
[14] |
Ridolfi R L,Rosen P P,Port A,et al.Medullary carcinoma of the breast:a clinicopathologic study with 10 year follow-up.Cancer,1997,40:1365-1385.
|
[15] |
Coronella J A,Spier C,Welch M,et al.Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast.J Immunol,2002,169:1829-1836.
|
[16] |
Nzula S,Going JJ,Stott D I.Antigen driven clonal proliferation,somatic hypermutation,and selection of B lymphocytes infiltrating human ductal breast carcinomas.Cancer Res,2003,63:3275-3280.
|
[17] |
Guo X,Fan Y,Lang R,et al.Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast.Mod Pathol,2008,21:1101-1107.
|
[18] |
Georgiannos S N,Renaut A,Goode A W,et al.The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers,the role of the major histocompatibility complex in cell-mediated immune mechanisms,and their association with prognostic indicators.Surgery,2003,134:827-834.
|
[19] |
Marrogi A J,Munshi A,Merogi A J,et al.Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma.Int J Cancer,1997,74:492-501.
|
[20] |
Macchetti A H,Marana H R,Silva J S,et al.Tumor-infiltrating CD4+T lymphocytes in early breast cancer reflect lymph node involvement.Clinics,2006,61:203-208.
|
[21] |
Leong P P,Mohammad R,Ibrahim N,et al.Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.Immunol Lett,2006,102:229-236.
|
[22] |
Shimizu M,Saitoh Y,Itoh H,et al.Immunohistochemical staining of Ha2ras oncogene product in normal,benign,and malignant human pancreatic tissues.Human Pathol,1990,21:607-612.
|
[23] |
Abbas A K,Murphy K M,Sher A.Functional diversity of helper T lymphocytes.Nature,1996,383:787-793.
|
[24] |
Romagnani S.Lymphokine production by human T cells in disease states.Annu Rev lmmunol,1994,12:227-257.
|
[25] |
Lauerova L,Dusek L,Simickova M,et al.Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response.Neoplasma,2002,49:159-166.
|
[26] |
Agarwal A,Ran i M,Saha G K,et al.Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma.Immunol Invest,2003,32:17-30.
|
[27] |
Todaro M,Zerilli M,RicciVitiani L.Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells.Cancer Res,2006,66:1491-1499.
|
[28] |
Abehsira Amar O,Gibert M,Joliy M,et al.IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells.J Immunol.1992,148:3820-3829.
|
[29] |
Hosken N A,Shibuya K,Heath A W,et al.The effect of antigen dose on CD4+T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model.J Exp Med,1995,182:1579-1584.
|
[30] |
Pfeiffer C,Stein S,Southwood S,et al.Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo.J Exp Med,1995,181:1569-1574.
|
[31] |
Constant S,Pfeiffer C,T.Woodard A,et al.Extent of T cell receptor ligation can determine the function differentiation of naive CD4+T cells.J Exp Med,1995,182:1591-1596.
|
[32] |
安云庆,高晓明.医学免疫学.北京:北京大学医学出版社,2004:185-187.
|
[33] |
Reinhard G,Noll A,Schlebusch H,et al.Shifts in the Th1/Th2 balance during human pregnancy correlate with apoptotic changes.Biochem Biophys Res Commun,1998,245:933-938.
|